标题
Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 3, Pages -
出版商
American Society for Microbiology
发表日期
2018-01-06
DOI
10.1128/aac.01475-17
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples
- (2018) Christine J. Kubin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
- (2016) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing guidance for intravenous colistin in critically-ill patients
- (2016) Roger L Nation et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
- (2016) Thien B. Tran et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study
- (2015) Maria Helena Rigatto et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New pharmacokinetic/pharmacodynamic studies of systemically administered colistin againstPseudomonas aeruginosaandAcinetobacter baumanniiin mouse thigh and lung infection models: smaller response in lung infection
- (2015) Soon-Ee Cheah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
- (2014) K. Phe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B Dosing in Obese and Underweight Adults
- (2013) M. P. Pai CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
- (2013) Darowan S. Akajagbor et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
- (2013) Felipe F. Tuon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
- (2012) Christine J. Kubin et al. JOURNAL OF INFECTION
- High Performance Liquid Chromatography–Mass Spectrometry Assay for Polymyxin B1 and B2 in Human Plasma
- (2012) Tiffany A. Thomas et al. THERAPEUTIC DRUG MONITORING
- Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
- (2012) Michael N. Neely et al. THERAPEUTIC DRUG MONITORING
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models
- (2010) R. V. Dudhani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin in the 21st century
- (2009) Roger L Nation et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
- (2007) Andrea L.H. Kwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started